Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Moodys
Express Scripts
Dow
Johnson and Johnson

Last Updated: October 19, 2019

DrugPatentWatch Database Preview

TRAZODONE HYDROCHLORIDE Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Trazodone Hydrochloride, and what generic alternatives are available?

Trazodone Hydrochloride is a drug marketed by Accord Hlthcare, Alvogen, Am Therap, Apotex, Apotex Inc, Aurolife Pharma Llc, Fosun Pharma, Mylan, Mylan Pharms Inc, Oxford Pharms, Pliva, Quantum Pharmics, Sun Pharm Industries, Teva, Teva Pharms Usa, Torrent, Usl Pharma, Watson Labs, and Zydus Pharms. and is included in twenty-eight NDAs.

The generic ingredient in TRAZODONE HYDROCHLORIDE is trazodone hydrochloride. There are fourteen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the trazodone hydrochloride profile page.

Summary for TRAZODONE HYDROCHLORIDE
US Patents:0
Applicants:19
NDAs:28
Suppliers / Packagers: 39
Bulk Api Vendors: 95
Clinical Trials: 48
Patent Applications: 1,337
Formulation / Manufacturing:see details
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for TRAZODONE HYDROCHLORIDE
DailyMed Link:TRAZODONE HYDROCHLORIDE at DailyMed
Drug patent expirations by year for TRAZODONE HYDROCHLORIDE
Recent Clinical Trials for TRAZODONE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
VA Office of Research and DevelopmentPhase 3
Erich SeifritzPhase 2
University Hospital, Basel, SwitzerlandPhase 4

See all TRAZODONE HYDROCHLORIDE clinical trials

Recent Litigation for TRAZODONE HYDROCHLORIDE

Identify potential future generic entrants

District Court Litigation
Case NameDate
Aziende Chimiche Riunite Angelini Francesco ACRAFSpA v. Intellipharmaceutics International Inc.2014-09-26

See all TRAZODONE HYDROCHLORIDE litigation

Pharmacology for TRAZODONE HYDROCHLORIDE
Drug ClassSerotonin Reuptake Inhibitor
Medical Subject Heading (MeSH) Categories for TRAZODONE HYDROCHLORIDE
Anti-Anxiety Agents
Antidepressive Agents, Second-Generation
Serotonin Uptake Inhibitors
Synonyms for TRAZODONE HYDROCHLORIDE
1,2,4-Triazolo(4,3-a)pyridin-3(2H)-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-, monohydrochloride
1,2,4-triazolo[4,3-a]pyridin-3(2H)-one hydrochloride
1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one,2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-,hydrochloride (1:1)
1,4-Triazolo[4,3-a]pyridin-3(2H)-one, 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-, monohydrochloride
19666-36-5
2-(3-(4-(3-Chlorophenyl)-1-piperazinyl)propyl)-s-triazolo(4,3-a)pyridin-3(2H)-one HCl
2-(3-(4-(3-Chlorophenyl)piperazin-1-y)propyl)-1,2,4-triazolo(4,3-a)pyridine-3(2H)-one hydrochloride
2-(3-(4-(3-chlorophenyl)piperazin-1-yl)propyl)-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride
2-(3-(4-(3-Chlorophenyl)piperazin-1-yl)propyl)-1,2,4-triazolo(4,3-a)pyridin-3(2H)-one hydrochloride
2-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-s-triazolo(4,3-a)pyridin-3(2H)-one monohydrochloride
2-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-
2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one hydrochloride
2-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one hydrochloride
2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one hydrochloride
2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;hydrochloride
2-[3-[4-(m-Chlorophenyl)-1-piperazinyl]propyl]-s-triazolo[4,3-a]pyridin-3(2H)-one monohydrochloride
2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-2H,3H-[1,2,4]triazolo[4,3-a]pyridin-3-one hydrochloride
2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride
2-{3-[4-(3-chlorophenyl)piperazinyl]propyl}-4-hydro-1,2,4-triazolino[4,3-a]pyr idin-3-one, chloride
25332-39-2
332T392
4CA-1276
6E8ZO8LRNM
A813950
A817789
AB2000676
AC-6779
AC1L1Y2P
AC1Q3BFE
AF 1161
AF-1161
AKOS015897762
AN-9680
Apo-Trazodone
Azona
BC215367
BCP04922
Bimaran
C19H22ClN5O.HCl
C19H23Cl2N5O
CAS-25332-39-2
CCG-40299
CHEBI:9655
CHEMBL1200798
CPD000058520
CS-2592
CT0209
CTK4F5497
D00820
Desyrel
Desyrel (TN)
Desyrel Dividose
Devidon
DSSTox_CID_24626
DSSTox_GSID_44626
DSSTox_RID_80361
DTXSID8044626
EINECS 243-216-2
EINECS 246-855-5
EU-0101159
FT-0659024
HMS1568L06
HMS1922G09
HSDB 7048
HY-B0478
I13-027
J-015941
J10153
Jsp005028
K-6661
KB-831
KS-00000ZWU
KS-5100
LP01159
LS-156736
MCULE-3098459714
MFCD00079603
MLS000069698
MLS000758230
MLS001148260
MLS001424009
Molipaxin
MolPort-001-684-664
NC00046
NCGC00016035-02
NCGC00016035-13
NCGC00094420-01
NCGC00094420-02
NCGC00094420-03
NCGC00094420-04
NCGC00256807-01
NCGC00261844-01
NSC 292811
NSC-292811
NSC-758393
NSC292811
NSC758393
Oleptro
Opera_ID_850
Pharmakon1600-01503121
Pragmazone
Prestwick_478
PubChem15888
s-Triazolo(4,3-a)pyridin-3(2H)-one, 2-(3-(4-(m-chlorophenyl)-1-piperazinyl)propyl)-, monohydrochloride
s-Triazolo(4,3-a)pyridin-3(2H)-one, 2-(3-(4-(m-chlorophenyl)-1-piperazinyl)propyl)-,monohydrochloride
S-Triazolo[4, 2-[3-[4-(m-chlorophenyl)-1-piperazinyl]propyl]-, monohydrochloride
S-Trizolo[4, 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-, hydrochloride
S2582
SAM001247045
SC-16187
SCHEMBL61754
SMR000058520
SPECTRUM1503121
SR-01000000190
SR-01000000190-2
SR-01000000190-8
ST2407780
ST51015149
T 6154
Thombran
Tombran
Tox21_110286
Tox21_110286_1
Tox21_302685
Tox21_501159
Trazodone (hydrochloride)
Trazodone Hcl
Trazodone hydrochloride (Desyrel)
Trazodone hydrochloride (JAN/USP)
Trazodone hydrochloride [USAN:JAN]
Trazodone hydrochloride [USAN:USP:JAN]
Trazodone Hydrochloride 1.0 mg/ml in Methanol (as free base)
Trazodone hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material
Trazodone hydrochloride, >=99% (HPLC), powder
Trazodone hydrochloride, United States Pharmacopeia (USP) Reference Standard
Trazodone, HCl
Trazolan
Tritico
Triticum
Trittico
UNII-6E8ZO8LRNM
VA11904
WLN: T56 ANVNNJ C3- AT6N DNTJ DR CG &GH
Z1550675462

US Patents and Regulatory Information for TRAZODONE HYDROCHLORIDE

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms TRAZODONE HYDROCHLORIDE trazodone hydrochloride TABLET;ORAL 205253-001 Oct 10, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Torrent TRAZODONE HYDROCHLORIDE trazodone hydrochloride TABLET;ORAL 202180-002 Nov 27, 2013 AB RX No No   Start Trial   Start Trial   Start Trial
Teva TRAZODONE HYDROCHLORIDE trazodone hydrochloride TABLET;ORAL 074357-001 Apr 30, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Torrent TRAZODONE HYDROCHLORIDE trazodone hydrochloride TABLET;ORAL 202180-003 Nov 27, 2013 AB RX No No   Start Trial   Start Trial   Start Trial
Teva Pharms Usa TRAZODONE HYDROCHLORIDE trazodone hydrochloride TABLET;ORAL 071523-001 Dec 11, 1987 AB RX No No   Start Trial   Start Trial   Start Trial
Accord Hlthcare TRAZODONE HYDROCHLORIDE trazodone hydrochloride TABLET;ORAL 206923-001 Sep 8, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Dow
McKinsey
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
Major Patent Expirations 2019 - 2020
 NCE-1 Generic Application Dates 2019 - 2020
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

DrugPatentWatch reviews